Comparing blood thinner duration after heart bypass surgery
Part of Heart & circulation clinical trials.
This study compares two different lengths of time for taking a blood thinner after heart bypass surgery to see which is safer and works better. It may help reduce the risk of blood clots or bleeding after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are scheduled for your first heart bypass surgery that uses at least one vein from your leg.
- You are not having any other heart surgery at the same time (like valve or rhythm surgery).
- You are not having emergency surgery.
- You have no history of severe bleeding, stomach ulcers, or bleeding in the brain in the past few years.
- You are not taking certain other blood thinners or anticoagulants that you cannot stop after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who had a first-time heart bypass operation (CABG) to see how a blood-thinning medicine called ticagrelor affects their recovery and long-term health. It may help doctors understand the best way to prevent complications after surgery.
This Phase 3 trial compares two strategies to prevent blood clots after heart bypass surgery: aspirin alone versus aspirin plus ticagrelor. It aims to see which approach works better and is safer for people whose bypass does not fully restore blood flow.
This study compares taking blood-thinning medicine for 1 month versus 6 months after a balloon angioplasty to open a small heart artery. The goal is to find out which duration is safer and more effective for preventing future heart problems.
This trial tests if people who have been on two blood thinners (aspirin plus prasugrel or ticagrelor) for at least 90 days after getting a heart stent can safely switch to just one of those blood thinners. It aims to see if taking only one pill is as safe and effective as taking two.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.